Drug intelligence / Profile preview

Yinxing Mihuan oral solution

Development stage
Unknown
Lead developer
Chengdu Tianyin Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Yinxing Mihuan oral solution is a modernized traditional Chinese medicine (mTCM) compound preparation composed of Ginkgo biloba extract (GBE) and Armillariella mellea (also known as Armillaria mellea) powder. It is widely used in China for the treatment of cardiovascular and cerebrovascular diseases, including coronary heart disease, angina pectoris, and ischemic stroke. The ginkgo leaf extract promotes blood circulation, removes blood stasis, and unblocks collaterals, while Armillariella mellea powder has sedative and neuroprotective effects. The combination exhibits synergistic antioxidant, anti-inflammatory, and vascular-regulating properties.

Other names
GAO solutionGMOLGinkgo Amillaria oral solutionGinkgo Biloba Extract/Armillaria mellea PowderGinkgo Leaf Extract and Armillariella Mellea Powders Oral SolutionGinkgo and Armillaria Oral SolutionYMOSYinxing Mihuan oral liquidYinxing-Mihuan-Oral-Liquid
02

Targets

IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on Yinxing Mihuan oral solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yinxing Mihuan oral solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call